HUE061100T2 - Adenovírus hõinaktiválásának módszerei - Google Patents
Adenovírus hõinaktiválásának módszereiInfo
- Publication number
- HUE061100T2 HUE061100T2 HUE17776462A HUE17776462A HUE061100T2 HU E061100 T2 HUE061100 T2 HU E061100T2 HU E17776462 A HUE17776462 A HU E17776462A HU E17776462 A HUE17776462 A HU E17776462A HU E061100 T2 HUE061100 T2 HU E061100T2
- Authority
- HU
- Hungary
- Prior art keywords
- adenovirus
- methods
- heat inactivation
- inactivation
- heat
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/761—Adenovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2523/00—Culture process characterised by temperature
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10361—Methods of inactivation or attenuation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662314116P | 2016-03-28 | 2016-03-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE061100T2 true HUE061100T2 (hu) | 2023-05-28 |
Family
ID=59966403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE17776462A HUE061100T2 (hu) | 2016-03-28 | 2017-03-28 | Adenovírus hõinaktiválásának módszerei |
Country Status (18)
Country | Link |
---|---|
US (2) | US11013774B2 (hu) |
EP (2) | EP3436593B1 (hu) |
JP (3) | JP7356224B2 (hu) |
KR (1) | KR102389674B1 (hu) |
CN (1) | CN109196106A (hu) |
AU (1) | AU2017241777B2 (hu) |
BR (1) | BR112018069703A2 (hu) |
CA (1) | CA3018380A1 (hu) |
DK (1) | DK3436593T3 (hu) |
ES (1) | ES2938833T3 (hu) |
FI (1) | FI3436593T3 (hu) |
HU (1) | HUE061100T2 (hu) |
IL (1) | IL261914B2 (hu) |
LT (1) | LT3436593T (hu) |
PL (1) | PL3436593T3 (hu) |
PT (1) | PT3436593T (hu) |
SG (1) | SG11201808183PA (hu) |
WO (1) | WO2017172772A1 (hu) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2017005834A (es) | 2014-11-05 | 2017-11-17 | Voyager Therapeutics Inc | Polinucleotidos aad para el tratamiento de la enfermedad de parkinson. |
AU2015346162B2 (en) | 2014-11-14 | 2022-02-10 | Voyager Therapeutics, Inc. | Compositions and methods of treating amyotrophic lateral sclerosis (ALS) |
CN112375760A (zh) | 2014-11-14 | 2021-02-19 | 沃雅戈治疗公司 | 调节性多核苷酸 |
WO2016094783A1 (en) | 2014-12-12 | 2016-06-16 | Voyager Therapeutics, Inc. | Compositions and methods for the production of scaav |
SG11201809699XA (en) | 2016-05-18 | 2018-12-28 | Voyager Therapeutics Inc | Modulatory polynucleotides |
JOP20190269A1 (ar) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | بولي نوكليوتيدات aadc لعلاج مرض باركنسون |
DK3898981T3 (da) | 2018-12-18 | 2024-01-22 | Ultragenyx Pharmaceutical Inc | Fremgangsmåder og sammensætninger til behandling af glykogenlagringssygdomme |
WO2023172491A1 (en) | 2022-03-07 | 2023-09-14 | Ultragenyx Pharmaceutical Inc. | Modified batch aav production systems and methods |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5436146A (en) | 1989-09-07 | 1995-07-25 | The Trustees Of Princeton University | Helper-free stocks of recombinant adeno-associated virus vectors |
US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
US5387484A (en) | 1992-07-07 | 1995-02-07 | International Business Machines Corporation | Two-sided mask for patterning of materials with electromagnetic radiation |
US5658785A (en) | 1994-06-06 | 1997-08-19 | Children's Hospital, Inc. | Adeno-associated virus materials and methods |
JP4216350B2 (ja) | 1994-09-19 | 2009-01-28 | 大日本住友製薬株式会社 | 動物細胞感染用の組換えdnaウイルスベクター |
US5872005A (en) | 1994-11-03 | 1999-02-16 | Cell Genesys Inc. | Packaging cell lines for adeno-associated viral vectors |
US6924128B2 (en) | 1994-12-06 | 2005-08-02 | Targeted Genetics Corporation | Packaging cell lines for generation of high titers of recombinant AAV vectors |
WO1996017947A1 (en) | 1994-12-06 | 1996-06-13 | Targeted Genetics Corporation | Packaging cell lines for generation of high titers of recombinant aav vectors |
IL116816A (en) | 1995-01-20 | 2003-05-29 | Rhone Poulenc Rorer Sa | Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof |
US5741683A (en) | 1995-06-07 | 1998-04-21 | The Research Foundation Of State University Of New York | In vitro packaging of adeno-associated virus DNA |
US5688676A (en) | 1995-06-07 | 1997-11-18 | Research Foundation Of State University Of New York | In vitro packaging of adeno-associated virus DNA |
US6027931A (en) | 1995-08-03 | 2000-02-22 | Avigen, Inc. | High-efficiency AA V helper functions |
ES2099678B1 (es) * | 1995-11-03 | 1998-02-16 | Grifols Grupo Sa | Procedimiento para la inactivacion de virus en proteinas. |
US6004797A (en) | 1995-11-09 | 1999-12-21 | Avigen, Inc. | Adenovirus helper-free recombinant AAV Virion production |
JP2001506133A (ja) | 1996-12-18 | 2001-05-15 | ターゲティッド ジェネティクス コーポレイション | 組換えaavベクターの産生における使用のための、aavスプリット−パッケージング遺伝子およびこのような遺伝子を含む細胞株 |
US6156303A (en) | 1997-06-11 | 2000-12-05 | University Of Washington | Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom |
US6566118B1 (en) | 1997-09-05 | 2003-05-20 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
US6995006B2 (en) | 1997-09-05 | 2006-02-07 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
CA2303768C (en) | 1997-09-19 | 2009-11-24 | The Trustees Of The University Of Pennsylvania | Methods and vector constructs useful for production of recombinant aav |
IT1297074B1 (it) | 1997-11-21 | 1999-08-03 | Angeletti P Ist Richerche Bio | Forme ormone-dipendenti delle proteine rep del virus adeno-associato (aav-2), sequenze di dna codificanti per esse, vettori che le |
JP2003528029A (ja) * | 1998-08-14 | 2003-09-24 | アヴェンティス ファーマシューティカルズ インコーポレイテッド | 遺伝子治療用のアデノウイルス配合物 |
AU764130B2 (en) | 1998-10-27 | 2003-08-14 | Crucell Holland B.V. | Improved AAV vector production |
DE19905501B4 (de) | 1999-02-10 | 2005-05-19 | MediGene AG, Gesellschaft für molekularbiologische Kardiologie und Onkologie | Verfahren zur Herstellung eines rekombinanten Adeno-assoziierten Virus, geeignete Mittel hierzu sowie Verwendung zur Herstellung eines Arzneimittels |
MXPA01010124A (es) * | 1999-04-09 | 2002-06-26 | Aventis Pharma Sa | Composiciones destinada a la conservacion de adenovirus recombinantes infecciosos. |
US20040235173A1 (en) | 2000-07-03 | 2004-11-25 | Gala Design, Inc. | Production of host cells containing multiple integrating vectors by serial transduction |
DE10061533B4 (de) | 2000-12-11 | 2006-05-04 | Amphenol-Tuchel Electronics Gmbh | Selbsttragende Kontaktfeder, insbesondere für einen Smartcard-Connector |
US7271002B2 (en) | 2001-11-09 | 2007-09-18 | United States Of America, Represented By The Secretary, Department Of Health And Human Services | Production of adeno-associated virus in insect cells |
US6723551B2 (en) | 2001-11-09 | 2004-04-20 | The United States Of America As Represented By The Department Of Health And Human Services | Production of adeno-associated virus in insect cells |
CA2369985A1 (en) | 2002-01-18 | 2003-07-18 | Duke University | Generation of recombinant adeno-associated viral vectors by a complete adenovirus-mediated approach |
WO2004075861A2 (en) | 2003-02-26 | 2004-09-10 | Children's Hospital, Inc. | Recombinant adeno-associated virus production |
BRPI0511764B8 (pt) | 2004-06-01 | 2021-05-25 | Avigen Inc | método de prevenção de agregação de vírions de vírus adeno-associado recombinante (raav) em uma preparação purificada de virions raav |
US7195394B2 (en) | 2004-07-19 | 2007-03-27 | Vijay Singh | Method for resonant wave mixing in closed containers |
US8980247B2 (en) | 2004-10-21 | 2015-03-17 | The Penn State Research Foundation | Parvovirus methods and compositions for killing neoplastic cells |
AU2006304997B2 (en) | 2005-10-20 | 2012-03-01 | Uniqure Ip B.V. | Improved AAV vectors produced in insect cells |
US9254318B2 (en) * | 2006-03-31 | 2016-02-09 | Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses for vaccines |
ES2785223T3 (es) | 2006-06-21 | 2020-10-06 | Uniqure Ip Bv | Células de insecto para la producción de vectores de AAV |
GB0706638D0 (en) | 2007-04-04 | 2007-05-16 | Mbda Uk Ltd | A high-dielectric material |
US8580755B2 (en) | 2008-02-19 | 2013-11-12 | University Of Rochester | Methods and compositions for treating inflammatory conditions |
CA2742151A1 (en) | 2008-11-07 | 2010-05-14 | Intelligentnano Inc. | Transfection with magnetic nanoparticles and ultrasound |
HUE028341T2 (hu) * | 2009-06-16 | 2016-12-28 | Genzyme Corp | Javított eljárások rekombináns AAV-vektorok tisztítására |
US20140359799A1 (en) | 2011-12-23 | 2014-12-04 | Case Western Reserve University | Targeted gene modification using hybrid recombinant adeno-associated virus |
AU2014205604B2 (en) | 2013-01-08 | 2020-01-02 | Genzyme Corporation | Use of iNOS inhibitors to increase viral yield in culture |
-
2017
- 2017-03-28 PT PT177764628T patent/PT3436593T/pt unknown
- 2017-03-28 DK DK17776462.8T patent/DK3436593T3/da active
- 2017-03-28 PL PL17776462.8T patent/PL3436593T3/pl unknown
- 2017-03-28 WO PCT/US2017/024545 patent/WO2017172772A1/en active Application Filing
- 2017-03-28 KR KR1020187030706A patent/KR102389674B1/ko active IP Right Grant
- 2017-03-28 AU AU2017241777A patent/AU2017241777B2/en active Active
- 2017-03-28 LT LTEPPCT/US2017/024545T patent/LT3436593T/lt unknown
- 2017-03-28 FI FIEP17776462.8T patent/FI3436593T3/fi active
- 2017-03-28 BR BR112018069703A patent/BR112018069703A2/pt unknown
- 2017-03-28 CA CA3018380A patent/CA3018380A1/en active Pending
- 2017-03-28 CN CN201780033212.1A patent/CN109196106A/zh active Pending
- 2017-03-28 US US16/085,177 patent/US11013774B2/en active Active
- 2017-03-28 HU HUE17776462A patent/HUE061100T2/hu unknown
- 2017-03-28 SG SG11201808183PA patent/SG11201808183PA/en unknown
- 2017-03-28 EP EP17776462.8A patent/EP3436593B1/en active Active
- 2017-03-28 EP EP22199443.7A patent/EP4159867A1/en active Pending
- 2017-03-28 JP JP2018550814A patent/JP7356224B2/ja active Active
- 2017-03-28 ES ES17776462T patent/ES2938833T3/es active Active
-
2018
- 2018-09-20 IL IL261914A patent/IL261914B2/en unknown
-
2021
- 2021-02-01 JP JP2021014329A patent/JP2021072838A/ja not_active Withdrawn
- 2021-04-23 US US17/238,743 patent/US11944658B2/en active Active
-
2022
- 2022-08-25 JP JP2022134006A patent/JP2022166304A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US20190083554A1 (en) | 2019-03-21 |
LT3436593T (lt) | 2023-03-10 |
EP3436593B1 (en) | 2022-11-23 |
KR20180130531A (ko) | 2018-12-07 |
EP4159867A1 (en) | 2023-04-05 |
IL261914B1 (en) | 2023-03-01 |
JP2019509747A (ja) | 2019-04-11 |
KR102389674B1 (ko) | 2022-04-21 |
US11013774B2 (en) | 2021-05-25 |
US11944658B2 (en) | 2024-04-02 |
CA3018380A1 (en) | 2017-10-05 |
EP3436593A1 (en) | 2019-02-06 |
WO2017172772A1 (en) | 2017-10-05 |
JP7356224B2 (ja) | 2023-10-04 |
CN109196106A (zh) | 2019-01-11 |
DK3436593T3 (da) | 2023-02-20 |
FI3436593T3 (fi) | 2023-03-16 |
PT3436593T (pt) | 2023-01-31 |
JP2021072838A (ja) | 2021-05-13 |
IL261914A (en) | 2018-10-31 |
PL3436593T3 (pl) | 2023-03-27 |
EP3436593A4 (en) | 2019-10-16 |
AU2017241777A1 (en) | 2018-10-11 |
AU2017241777B2 (en) | 2022-02-03 |
US20220072073A1 (en) | 2022-03-10 |
SG11201808183PA (en) | 2018-10-30 |
BR112018069703A2 (pt) | 2019-02-05 |
JP2022166304A (ja) | 2022-11-01 |
IL261914B2 (en) | 2023-07-01 |
ES2938833T3 (es) | 2023-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3218942A4 (en) | Heating and cooling technologies | |
IL261914B1 (en) | Methods for heat inactivation of adenovirus | |
HUE051924T2 (hu) | Hõkezelési eljárás | |
PT2905346T (pt) | Método de tratamento térmico | |
PL3122349T3 (pl) | Kompozycje do leczenia samotrawienia | |
GB201706677D0 (en) | Cooling of rotating control device | |
GB201416832D0 (en) | Methods of treatment | |
HK1249866A1 (zh) | 用他塞利昔布進行治療的方法 | |
PT3112766T (pt) | Controlador de equipamento de fonte de calor | |
PL3249329T3 (pl) | Aparat do obróbki cieplnej | |
DK3226731T3 (da) | Varmluftkogegrej | |
GB2525708B (en) | Heating and/or cooling assembly | |
HUE047616T2 (hu) | Hõelvezetõ | |
EP3333525A4 (en) | Heat treatment apparatus | |
EP3333526A4 (en) | HEAT TREATMENT DEVICE | |
EP3249330A4 (en) | Heat treatment device | |
EP3138930A4 (en) | Cooling device and multi-chamber heat treatment device | |
GB2558216B (en) | Method of heat treatment | |
GB201518848D0 (en) | Thermal treatment device | |
GB201412010D0 (en) | Treatment of hypertransaminasemia | |
GB201512139D0 (en) | Methods of treatment | |
SG11201604943SA (en) | Radiant cooling and heating apparatus | |
GB201609455D0 (en) | Thermal reduction therapy | |
TWM533492U (en) | Improved structure of heat pad | |
GB2525963B (en) | Apparatus for providing three separate functions of heating, cooling, and simultaneous heating and cooling |